2016
DOI: 10.1007/s12281-016-0263-4
|View full text |Cite
|
Sign up to set email alerts
|

Primary and Disseminated Cutaneous Coccidioidomycosis: Clinical Aspects and Diagnosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 68 publications
0
1
0
Order By: Relevance
“…3 In a limited setting where culture or serologic studies are not available, the diagnosis of primary cutaneous coccidioidomycosis could be stabilised with the clinical history, physical examination, histopathological findings (spherules and endospores) and a normal chest X-ray. 3,4 The first-line therapy currently recommended for softtissue coccidioidomycosis without bone involvement is oral fluconazole 400-800 mg/day or oral itraconazole 200 mg twice daily. Amphotericin B is recommended in case of azole failure.…”
Section: Discussionmentioning
confidence: 99%
“…3 In a limited setting where culture or serologic studies are not available, the diagnosis of primary cutaneous coccidioidomycosis could be stabilised with the clinical history, physical examination, histopathological findings (spherules and endospores) and a normal chest X-ray. 3,4 The first-line therapy currently recommended for softtissue coccidioidomycosis without bone involvement is oral fluconazole 400-800 mg/day or oral itraconazole 200 mg twice daily. Amphotericin B is recommended in case of azole failure.…”
Section: Discussionmentioning
confidence: 99%